Total Valuation
Actinogen Medical has a market cap or net worth of $100.85M. The enterprise value is $119.44M.
Market Cap$100.85M
Enterprise Value$119.44M
Share Statistics
Actinogen Medical has 3,717,091,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,717,091,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Actinogen Medical ’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is -43.37%.
Return on Equity (ROE)-0.80
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-43.37%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee914.93K
Profits Per Employee-2.46M
Employee Count6
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical is ―. Actinogen Medical ’s PEG ratio is 0.25.
PE Ratio―
PS Ratio12.48
PB Ratio3.74
Price to Fair Value3.74
Price to FCF-9.03
Price to Operating Cash Flow-8.54
PEG Ratio0.25
Income Statement
In the last 12 months, Actinogen Medical had revenue of 5.49M and earned -14.73M in profits. Earnings per share was >-0.01.
Revenue5.49M
Gross Profit5.49M
Operating Income-14.93M
Pretax Income-14.73M
Net Income-14.73M
EBITDA-15.01M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -16.41M and capital expenditures -38.37K, giving a free cash flow of -16.45M billion.
Operating Cash Flow-16.41M
Free Cash Flow-16.45M
Free Cash Flow per Share>-0.01
Dividends & Yields
Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-6.38
52-Week Price Change55.00%
50-Day Moving Average0.19
200-Day Moving Average0.07
Relative Strength Index (RSI)23.44
Average Volume (3m)1.75K
Important Dates
Actinogen Medical upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Actinogen Medical as a current ratio of 3.76, with Debt / Equity ratio of 4.38%
Current Ratio3.76
Quick Ratio3.76
Debt to Market Cap0.04
Net Debt to EBITDA0.88
Interest Coverage Ratio-305.42
Taxes
In the past 12 months, Actinogen Medical has paid -5.49M in taxes.
Income Tax-5.49M
Effective Tax Rate0.37
Enterprise Valuation
Actinogen Medical EV to EBITDA ratio is -3.68, with an EV/FCF ratio of -7.28.
EV to Sales10.07
EV to EBITDA-3.68
EV to Free Cash Flow-7.28
EV to Operating Cash Flow-7.32
Balance Sheet
Actinogen Medical has $6.53M in cash and marketable securities with $366.31K in debt, giving a net cash position of $6.17M billion.
Cash & Marketable Securities$6.53M
Total Debt$366.31K
Net Cash$6.17M
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 96.16%, with operating margin of -272.01%, and net profit margin of -268.37%.
Gross Margin96.16%
Operating Margin-272.01%
Pretax Margin-268.37%
Net Profit Margin-268.37%
EBITDA Margin-273.48%
EBIT Margin-279.70%
Analyst Forecast
The average price target for Actinogen Medical is $0.06, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$0.06
Price Target Upside85.52% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-63.64%